CymitQuimica logo

CAS 1193111-39-5

:

Ordinare per

Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
5 prodotti.
  • Butanoic acid, 4-(2-pyridinyldithio)-2-sulfo-, 1-(2,5-dioxo-1-pyrrolidinyl) ester

    CAS:
    Formula:C13H14N2O7S3
    Purezza:92%
    Colore e forma:Solid
    Peso molecolare:406.4545

    Ref: IN-DA000IKE

    5mg
    673,00€
    10mg
    Prezzo su richiesta
    25mg
    Prezzo su richiesta
    50mg
    Prezzo su richiesta
  • 1-(2,5-dioxopyrrolidin-1-yloxy)-1-oxo-4-(pyridin-2-yldisulfanyl)butane-2-sulfonic acid

    CAS:
    1-(2,5-dioxopyrrolidin-1-yloxy)-1-oxo-4-(pyridin-2-yldisulfanyl)butane-2-sulfonic acid
    Purezza:≥95%

    Ref: 54-OR471225

    ne
    Prezzo su richiesta
  • sulfo-SPDB

    CAS:
    sulfo-SPDB is a cleavable linker vital in ADC synthesis.
    Formula:C13H14N2O7S3
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:406.45

    Ref: TM-T18732

    100mg
    Prezzo su richiesta
    500mg
    Prezzo su richiesta
  • sulfo-SPDB

    CAS:
    Purezza:92%
    Peso molecolare:406.44

    Ref: 10-F986756

    5mg
    482,00€
  • sulfo-SPDB

    CAS:
    Sulfo-SPDB is a lysine analog that has potent antitumor activity and is being evaluated as a potential cancer therapeutic agent. It inhibits tumor growth in vitro by inhibiting the expression of proteins important for cell division and survival. Sulfo-SPDB binds to the lysine residues on the surface of cells, including erythrocytes, lymphocytes, and tumor cells. This binding prevents protein synthesis and cell division. In vivo studies have shown that sulfo-SPDB is effective against human liver cancer xenografts in mice, cervical cancer xenografts in mice, and t-cell lymphoma xenografts in mice. Clinical studies are underway to determine if it is safe for use in humans.
    Formula:C13H14N2O7S3
    Purezza:Min. 95%
    Peso molecolare:406.5 g/mol

    Ref: 3D-TXB11139

    100mg
    3.861,00€
    250mg
    6.434,00€